PHARMACY

CVS Health survey: More consumers likely to get flu shot this season
Knowledge of last year's high flu levels is encouraging consumers to get vaccinated this season, according to a recent survey by CVS Health.
FDA approves Cipla’s generic Reyataz
The product had a market value of approximately $324 million for the 12-month period ending April 2018, according to IQVIA data.

Mylan launches generic Adcirca tablets

Mylan's tadalafil tablets are the first generic version of Eli Lilly's Adcirca for pulmonary arterial hypertension.
Perrigo, Merck partner on Nasonex OTC Switch

Alongside it shedding its pharmaceutical business, Perrigo said it had entered an exclusive agreement with a subsidiary of Kenilworth, N.J.-based Merck to develop an over-the-counter formulation of Merck’s Nasonex nasal spray
FDA gives Amicus OK for Galafold for Fabry disease

Amicus Therapeutics' Galafold (migalastat) is the first oral medication for the treatment of adults with Fabry disease.
US Bioservices to dispense Alnylam's Onpattro injection

US Bioservices, a part of AmerisourceBergen will provide comprehensive specialty pharmacy services to patients who are being treated with Alnylam's Onpattro.
FDA gives nod to Alnylam's Onpattro for peripheral nerve disease

Onpattro is the first-of-its kind targeted RNA-based therapy for peripheral nerve disease approved by the FDA.
Perrigo to separate its prescription drug unit

Perrigo’s plan to shed its prescription drug business is part of its plan to grow its consumer health business, the company said.
Hikma launches sterile water for injection

Hikma said it hopes its product launch will reduce the shortage of sterile water injection in hospitals.
FDA commissioner Gottlieb touts record number of generic drug approvals in July

July was a very good month for generic drug approvals, with the FDA giving its full approval for 96 drugs, and tentative approval for 30 drugs.